1. Home
  2. SXT vs LNTH Comparison

SXT vs LNTH Comparison

Compare SXT & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sensient Technologies Corporation

SXT

Sensient Technologies Corporation

HOLD

Current Price

$90.68

Market Cap

4.0B

Sector

Industrials

ML Signal

HOLD

Logo Lantheus Holdings Inc.

LNTH

Lantheus Holdings Inc.

HOLD

Current Price

$62.52

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SXT
LNTH
Founded
1882
1956
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
4.2B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
SXT
LNTH
Price
$90.68
$62.52
Analyst Decision
Buy
Buy
Analyst Count
2
6
Target Price
$110.00
$74.17
AVG Volume (30 Days)
283.7K
1.1M
Earning Date
10-31-2025
11-06-2025
Dividend Yield
1.77%
N/A
EPS Growth
56.32
N/A
EPS
3.27
2.39
Revenue
$1,595,084,000.00
$1,525,933,000.00
Revenue This Year
$4.80
$0.01
Revenue Next Year
$5.94
$1.24
P/E Ratio
$28.25
$26.45
Revenue Growth
4.25
1.95
52 Week Low
$66.15
$47.25
52 Week High
$121.54
$111.29

Technical Indicators

Market Signals
Indicator
SXT
LNTH
Relative Strength Index (RSI) 38.21 68.58
Support Level $92.41 $57.44
Resistance Level $96.77 $64.40
Average True Range (ATR) 2.32 2.16
MACD -0.37 0.80
Stochastic Oscillator 1.39 86.90

Price Performance

Historical Comparison
SXT
LNTH

About SXT Sensient Technologies Corporation

Sensient Technologies Corp manufactures and markets natural and synthetic colors, flavors, and other specialty ingredients. Sensient's offerings are predominantly applied to consumer-facing products, including food and beverage, cosmetics and pharmaceuticals, nutraceuticals, and personal care industries. Its principal products are flavors, flavor enhancers, ingredients, extracts, and bionutrients, essential oils, dehydrated vegetables and other food ingredients, natural and synthetic food and beverage colors, and others. The company's reportable segments are; Flavors & Extracts, which derive key revenue, Color, Asia Pacific, and Corporate and Other. Geographically, the company generates maximum revenue from North America, followed by Europe, Asia-Pacific, and other regions.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

Share on Social Networks: